A protein panel in cerebrospinal fluid for diagnostic and predictive assessment of Alzheimer’s disease is a research paper published in Science Translational Medicine (2023). On theSindex it has a DataRank of 0.641. It has been cited 71 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.641
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIA NIH HHS
Grant: U01 AG024904
NIA NIH HHS
Grant: P30 AG066511
NIA NIH HHS
Grant: RF1 AG057471
NIA NIH HHS
Grant: U01 AG061357
NIA NIH HHS
Grant: U24 AG021886
NIA NIH HHS
Grant: R01 AG061800
NIA NIH HHS
Grant: R01 AG075827
NIA NIH HHS
Grant: R01 AG056533
NIA NIH HHS
Grant: RF1 AG062181
NIA NIH HHS
Grant: U19 AG024904
NIA NIH HHS
Grant: R01 AG072120
NIA NIH HHS
Grant: R01 AG079170
NIA NIH HHS
Grant: R01 AG087250
NIA NIH HHS
Grant: R01 AG070937
National Institutes of Health
Grant: 1U01AG024904-01
Alzheimers Disease Neuroimaging Initiative
FWCI
10.43
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 2 of Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients
Additional file 2 of Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients
Additional file 1 of Potential prognostic value of CSF-targeted proteomics across the Alzheimer’s disease continuum
Additional file 1 of Potential prognostic value of CSF-targeted proteomics across the Alzheimer’s disease continuum
Additional file 1 of Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease
Additional file 1 of Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease
Additional file 2 of Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease
Additional file 2 of Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease
Additional file 3 of Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease
Additional file 3 of Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease
Additional file 4 of Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease
Additional file 4 of Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer’s disease
Additional file 1 of Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients
Additional file 1 of Cerebrospinal fluid shotgun proteomics identifies distinct proteomic patterns in cerebral amyloid angiopathy rodent models and human patients